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Abstract
Background: Alternative macrophages (M2) express the cluster differentiation (CD) 206 (MCR1) at high levels. Decreased M2
in adipose tissue is known to be associated with obesity and inflammation-related metabolic disturbances. Here we aimed
to investigate MCR1 relative to CD68 (total macrophages) gene expression in association with adipogenic and mitochondrial
genes, which were measured in human visceral [VWAT, n = 147] and subcutaneous adipose tissue [SWAT, n = 76] and in
rectus abdominis muscle (n = 23). The effects of surgery-induced weight loss were also longitudinally evaluated (n = 6).
Results: MCR1 and CD68 gene expression levels were similar in VWAT and SWAT. A higher proportion of CD206 relative to
total CD68 was present in subjects with less body fat and lower fasting glucose concentrations. The ratio MCR1/CD68was
positively associated with IRS1gene expression and with the expression of lipogenic genes such as ACACA, FASN and THRSP,
even after adjusting for BMI. The ratio MCR1/CD68 in SWAT increased significantly after the surgery-induced weight loss
(+44.7%; p = 0.005) in parallel to the expression of adipogenic genes. In addition, SWAT MCR1/CD68ratio was significantly
associated with muscle mitochondrial gene expression (PPARGC1A, TFAM and MT-CO3). AT CD206 was confirmed by
immunohistochemistry to be specific of macrophages, especially abundant in crown-like structures.
Conclusion: A decreased ratio MCR1/CD68 is linked to adipose tissue and muscle mitochondrial dysfunction at least at the
level of expression of adipogenic and mitochondrial genes.
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Introduction
Obesity is associated with increased macrophage accumulation
in adipose tissue [1]. Expression analysis of macrophage and non-
macrophage cell populations isolated from adipose tissue demon-
strate that adipose tissue macrophages are responsible for most of
the proinflammatory cytokines and might contribute to obesity-
linked inflammatory and metabolic complications [1–4]. Macro-
phages can exist in a proinflammatory classical state activated by
interferon-c or lipopolysaccharide, known as M1, or in an anti-
inflammatory alternative state activated by IL-13 or IL-4, known
as M2 [5]. Adipose tissue macrophages (ATMs) are composed of
cells expressing MCR1, which is a marker of M2-activated
macrophages [6,7]. Recently, several studies reported that M2
macrophages in human and mouse adipose tissue were associated
with less adipose tissue inflammation and obesity-associated
metabolic disturbances [8–10]. A recent study in mice showed
that early stages of adipose tissue expansion are characterized by
M2-polarized ATMs and that progressive lipid accumulation
within ATMs promotes the M1 polarization, a macrophage
phenotype associated with severe obesity and insulin resistance.
This polarization was reversed with rosiglitazone treatment, which
promotes redistribution of lipids towards adipocytes, improving
the adipose tissue lipid storage capacity [11].
In recent years, the interaction between adipose and muscle
tissue has been increasingly recognized to play an important role
in body weight regulation. Muscle mitochondrial dysfunction,
which has been defined as a reduction in muscle oxidative capacity
and mitochondrial biogenesis, has been associated with obesity,
insulin resistance and type 2 diabetes [12–16]. Reduced levels of
muscle PPARGC1A, TFAM and MT-CO3 mRNA levels have
been used to evaluate muscle mitochondrial dysfunction
[12,13,16].
We are not aware of studies in humans aimed to search for
alternative macrophages in association with adipogenic genes,
which may be used as markers for adipose tissue function: the
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higher the adipogenic gene expression, the higher the lipid storage
capacity, or with muscle mitochondrial dysfunction in obese
subjects.
We investigated the association of MCR1 and CD68 (a widely
used macrophage marker, present in all macrophages subpopu-
lations, M1 and M2) with the expression of adipose tissue-
adipogenic genes in both cross-sectional and longitudinal (surgery-
induced weight loss) studies, and with muscle mitochondrial genes
(such as PPARGC1A, TFAM and MT-CO3).
Materials and Methods
CD68 and CD206 expression in adipose tissue, stromal
vascular fraction (SVF) and in isolated adipocytes
A group of 147 visceral and 76 subcutaneous adipose tissue
samples from participants, who were recruited at the Endocrinol-
ogy Department of the Hospital Virgen de la Victoria (Malaga,
Spain) and at the Endocrinology Service of the Hospital
Universitari Dr. Josep Trueta (Girona, Spain), were analyzed.
Finally, in a subgroup of 23 participants, muscle tissues (rectus
abdominis muscle) were also obtained. All subjects were of
Caucasian origin and reported that their body weight had been
stable for at least three months before the study. Liver and renal
diseases were specifically excluded by biochemical work-up, which
consisted of specific liver and kidney functional tests. All subjects
gave written informed consent, validated and approved by the
ethical committee of the Hospital Universitari Dr. Josep Trueta
and of the Hospital Virgen de la Victoria (Comite` d’E`tica
d’Investigacio´ Clı´nica, CEIC), after the purpose of the study was
explained to them. Both the ethical committee of the Hospital
Universitari Dr. Josep Trueta and the ethical committee of the
Hospital Virgen de la Victoria specifically approved this study
(ethical approval number 2008004). Adipose tissue samples were
obtained from subcutaneous and visceral depots during elective
surgical procedures (cholecystectomy, surgery of abdominal hernia
and gastric by-pass surgery). Both subcutaneous and visceral fat
were obtained from the abdomen, following standard procedures.
To analyse adipose tissue and muscle gene expression, tissues were
washed, fragmented and immediately flash-frozen in liquid
nitrogen before stored at 280uC.
To perform the isolation of adipocyte and SVF, tissues were
washed three to four times with phosphate-buffered saline (PBS)
and suspended in an equal volume of PBS supplemented with 1%
penicillin-streptomicin and 0.1% collagenase type I prewarmed to
37uC. The tissue was placed in a shaking water bath at 37uC with
continuous agitation for 60 minutes and centrifuged for 5 minutes
at 300 to 500 g at room temperature. The supernatant, containing
mature adipocytes, was recollected. The pellet was identified as the
SVF cell. The adipose tissue fractionation was performed from 12
visceral and 10 subcutaneous depots.
Study of the effects of weight loss induced by bariatric
surgery
Six Caucasian morbidly obese (BMI = 50.469.0 kg/m2,
age = 40610 years [mean 6 SD]) women with normal glucose
Figure 1. CD68 and MCR1 gene expression in subcutaneous (n = 10) and visceral (n = 12) adipose tissue fractions (SVCs and
adipocytes).
doi:10.1371/journal.pone.0070810.g001
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metabolism were recruited. The nature and purpose of the study
were carefully explained to all subjects before they provided their
written consent to participate.
At the time of the baseline study, all subjects were consuming a
diet with the following average composition: 60% carbohydrate,
30% fat, and 10% protein (,1 g/kg body weight). This dietary
regimen was maintained for 1 week before the study. Patients
underwent a clinical assessment including medical history, physical
examination, body composition analysis, and co-morbidity eval-
uation, as well as nutritional interviews performed by a
multidisciplinary consultation team. An oral glucose tolerance test
(OGTT), an intravenous glucose tolerance test (IVGTT), and a
euglycemic hyperinsulinemic clamp (EHC) were randomly per-
formed within 1 month before surgery and 1 month after surgery.
All patients received the same parenteral nutrition regimen
(,7,100 kJ/day) during the first 6 days after surgery; then they
were free to consume a normal diet. All subjects were non-smokers
and were not receiving statins or antidiabetic medication. Patients
with signs of infection were excluded.
The malabsorptive surgical procedure consisted of a ,60%
distal gastric resection with stapled closure of the duodenal stump.
The residual volume of the stomach is about 300 ml. The small
bowel is transected at 2.5 m from the ileocecal valve, and its distal
end is anastomosed to the remaining stomach. The proximal end
of the ileum, comprising the remaining small bowel (involved in
carrying biliopancreatic juice but excluded from food transit), is
anastomosed in an end-to-side fashion to the bowel, 50 cm
proximal to the ileocecal valve. Consequently, the total length of
absorbing bowel is reduced to 250 cm, the final 50 cm of which,
the so-called common channel, represents the site where ingested
food and biliopancreatic juices mix.
The malabsorptive surgical procedure was performed as
previously described [17] and subcutaneous adipose tissue samples
and metabolic studies were again performed 2 years later. All
subjects gave written informed consent, validated and approved by
the institutional ethics committee of the Catholic University of
Rome, after the purpose of the study was explained to them. The
institutional ethics committee of the Catholic University of Rome
specifically approved this study.
Study of gene expressions
RNA was prepared from these samples using RNeasy Lipid
Tissue Mini Kit (QIAgen, US). The integrity of each RNA sample
was checked by Agilent Bioanalyzer (Agilent Technologies, Palo Alto,
CA). Total RNA was quantified by means of spectrophotometer
(GeneQuant, GE Health Care, Piscataway NJ) reverse transcribed to
cDNA using High Capacity cDNA Archive Kit (Applied Biosystems,
Darmstadt, Germany) according to the manufacturer’s protocol.
Gene expression was assessed by real time PCR using an ABI
Prism 7000 Sequence Detection System (Applied Biosystems,
Darmstadt, Germany), using TaqManH and SybrGreen technology
suitable for relative gene expression quantification.
The commercially available and pre-validated TaqManH
primer/probe sets used were as follows: endogenous control PPIA
(4333763, cyclophilin A) and target genes CD68 (CD68,
Hs00154355_m1), mannose receptor, C type 1 (MRC1 or
CD206, Hs00267207_m1), fatty acid synthase (FASN,
Hs00188012_m1), acetyl-Coenzyme A carboxylase alpha (ACC,
Hs00167385_m1), insulin receptor substrate 1 (IRS1,
Hs00178563_m1), SPOT14 homolog (THRSP,
Hs00930058_m1), leptin (LEP, Hs00174877_m1). Human
PPARGC1A [forward: 59- GCAATTGAA-
Figure 2. Immunofluorescence detection of CD206 and CD68 in human adipose tissue crown-like structures. Co-staining of adipose
tissue macrophages in ‘‘crown-like structures’’ demonstrates co-localization of CD206 (red) and CD68 (green) proteins in most of the cells (A). Close-
up view of a CLS (B) The counterstaining of nuclei (DAPI) is shown in blue. Images are representative of adipose tissue preparations collected from
three subjects. Scale bar, 50 mm (A) and 25 mm (B).
doi:10.1371/journal.pone.0070810.g002
MRC1/CD68, Adipose Tissue and Muscle
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GAGCGCCGTGTGA-39 and reverse: 59- CTGTCTCCAT-
CATCCCGCAGAT-39], TFAM [forward: 59- AAGATTCCAA-
GAAGCTAAGGGTGA-39and reverse: 59- CAGAGTCAGACA-
GATTTTTCCAGTTT-39], MT-CO3 [forward: 59-
GCCCCCAACAGGCATCA-39 and reverse: 59-
GGATGTGTTTAGGAGTGGGACTTC-39] were measure us-
ing SYBRgreen technology.
The RT-PCR TaqManH reaction was performed in a final
volume of 25 ml. The cycle program consisted of an initial
denaturing of 10 min at 95uC then 40 cycles of 15 sec
denaturizing phase at 95uC and 1min annealing and extension
phase at 60uC. A threshold cycle (Ct value) was obtained for each
amplification curve and a DCt value was first calculated by
subtracting the Ct value for human Cyclophilin A (PPIA) RNA from
the Ct value for each sample. Fold changes compared with the
endogenous control were then determined by calculating 22DCt, so
gene expression results are expressed as expression ratio relative to
PPIA gene expression according to manufacturers’ guidelines.
Immunofluorescence
Five-micron sections of formalin-fixed paraffin-embedded adi-
pose tissue were deparaffinised and rehydrated prior to antigen
unmasking by boiling in 1 mM EDTA, pH 8. Sections were
blocked in normal serum and incubated overnight with mouse anti
CD206 antibody at 1:50 dilution, and rabbit anti CD68 at 1:50
dilution, washed, and visualized using Alexa Fluor 488 goat anti-
mouse antibody and Alexa Fluor 546 goat anti-rabbit (1:500;
Molecular Probes Inc, OR, USA), respectively. As a negative
control, the entire immunofluorescence procedure was performed
in the absence of primary antibody. The slides were counter-
stained with DAPI (4,6-diamidino-2-phenylindole) to reveal nuclei
and examined under a Leica TCS SP5 fluorescent microscope
(Heidelberg, Germany).
Statistical analyses
Statistical analyses were performed using SPSS 12.0 software.
Unless otherwise stated, descriptive results of continuous variables
are expressed as mean and SD for Gaussian variables, or median
and interquartile range. Parameters that did not fulfill normal
distribution were mathematically transformed to improve symme-
try for subsequent analyses. The relation between variables was
analyzed by simple correlation (Spearman’s test). One-way
ANOVA (using Bonferroni Post hoc test) was used to compare
clinical variables and CD206 and CD68 gene expressions
according to obesity status and adipose tissue fractions. Statistical
significance was set at P,0.05.
Results
As expected, CD68 and MCR1 gene expression were signifi-
cantly increased in stromal vascular cell fraction (SVF) in
comparison with adipocytes (Figure 1). Immunostaining analyses
were performed to determine the cellular distribution of CD206
protein adipose tissue. Immunofluorescence showed a bright
staining pattern in cells resembling adipose tissue macrophages. In
fact, CD206 stained cells were well represented in inflammatory
crown like structures (CLS) (Figure 2). Co-staining analysis using
CD206 and CD68 antibodies showed that most of the CD206 cells
were also stained with CD68 antibody. However a few cells
remained stained only for CD206 in the CLS.
Anthropometrical and clinical data from the participants are
detailed in Table 1. The levels of gene expression of CD68, MCR1
and MCR1/CD68 were similar in both visceral and subcutaneous
adipose tissue. In visceral adipose tissue, MCR1/CD68 ratio was
reduced in obese subjects, mainly in those with type 2 diabetes,
whereas CD68 gene expression was increased. MCR1 gene
expression did not change according to obesity or type 2 diabetes
(Table 1).
A higher proportion of MCR1 relative to total CD68
macrophages was present in subjects with less body fat [BMI
(r =20.44, p,0.0001), fat mass (r =20.44, p,0.0001)] and less
fasting glucose concentrations (r =20.17, p = 0.04). Interestingly,
the ratio MCR1/CD68 was positively associated with IRS1 (r = 0.4,
p,0.0001) and ADIPOQ gene expression (r = 0.4, p,0.0001) and
with expression measures for lipogenic genes such as ACACA
(r = 0.36, p,0.0001), FASN (r = 0.44, p,0.0001) and THRSP
(r = 0.43, p,0.0001). In multiple linear regression models, IRS1
(b= 0.24 p = 0.003, R2 = 0.17), ADIPOQ (b= 0.77 p,0.0001,
R2 = 0.55), THRSP (b= 0.20 p = 0.04, R2 = 0.15), FASN (b= 0.19
p = 0.045, R2 = 0.13) but not ACACA (b= 0.15 p = 0.06, R2 = 0.10)
Table 1. Anthropometrical and clinical parameters.
Non-
obese Obese
Obese
T2DM p
N 59 56 31
Sex 23/36 10/46 8/23
Age (years) 49.1614.8 46.5613.6 46.3611.7 0.5
BMI (Kg/m2) 24.762.9 44.168.6* 40.968.03* ,0.0001
Fat mass (%) 31.3767.1 56.44611.2* 51.6611.4* ,0.0001
Fasting glucose
(mg/dl)
83.2610.4 95.9613.8* 136.6655.8*# ,0.0001
Fasting Insulin
(mU/ml)
12.1166.1 14.0967.1 18.3568.2* 0.01
HOMA-IR 2.4961.2 3.561.9 5.862.3*# ,0.0001
In VWAT
IRS1+ 0.01760.011 0.0160.005 0.00960.004 ,0.0001
LEP+ 0.1560.12 0.2960.14* 0.4060.21* ,0.0001
THRSP+ 0.5560.4 0.1860.1* 0.1160.07* ,0.0001
FASN+ 0.2760.12 0.07660.060* 0.06160.050* ,0.0001
ACC1+ 0.03260.02 0.01660.010* 0.01460.011* ,0.0001
CD68+ 0.1260.07 0.1860.07* 0.2360.1* ,0.0001
CD206+ 0.02260.018 0.02160.013 0.02160.010 0.8
CD206/
CD68+
0.1860.08 0.1260.08* 0.1160.07* ,0.0001
In SWAT
IRS1+ 0.01060.005 0.01160.006 0.00960.003 0.2
LEP+ 1.0960.3 0.9760.3 0.8160.26 0.2
THRSP+ 0.4660.1 0.3860.2 0.3760.2 0.5
FASN+ 0.2560.20 0.0660.04* 0.0560.03* ,0.0001
ACC1+ 0.01960.009 0.02160.01 0.01660.006 0.3
CD68+ 0.1760.05 0.260.1 0.2260.09 0.5
CD206+ 0.01360.005 0.01660.01 0.01860.009 0.3
CD206+/
CD68+
0.07660.018 0.08460.03 0.08860.028 0.6
+Relative gene expression (R.U.).
The data are expressed as mean 6 standard deviation.
VWAT, visceral white adipose tissue; SWAT, subcutaneous white adipose tissue;
T2DM, Type 2 Diabetes Mellitus; HOMA, Homeostasis Model Assessment; R.U.,
relative gene expression units.
*p,0.05 compared with non-obese participants, performing Bonferroni post
hoc test.
doi:10.1371/journal.pone.0070810.t001
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gene expression contributed independently to MCR1/CD68 gene
expression variance after adjusting for BMI. Oppositely, CD68
gene expression was directly correlated with BMI (r = 0.45,
p,0.0001), fat mass (r = 0.41, p,0.0001), fasting glucose
(r = 0.18, p = 0.03), and with the gene expression of LEP
(r = 0.27, p = 0.009), and negatively correlated with IRS1
(r =20.17, p = 0.04), THRSP (r =20.29, p = 0.002), ACACA
(r =20.24, p = 0.01), FASN (r =20.31, p,0.0001). These associ-
ations were lost after controlling for BMI. No associations were
observed among CD68, MCR1/CD68 and fasting insulin or
HOMA-IR values.
In subcutaneous adipose tissue (SWAT), MCR1/CD68 and
CD68 were not significantly associated with obesity or type 2
diabetes (Table 1). The ratio MCR1/CD68 was positively
associated with ADIPOQ gene expression (r = 0.36, p,0.0001).
Interestingly, in a subcohort of 23 participants, where muscle
biopsies were available, SWAT MCR1/CD68 ratio and ADIPOQ
gene expression was significantly associated with the gene
expression of mitochondrial biogenesis and activity in muscle
(PPARGC1A, TFAM and MT-CO3, Figure 3).
Weight loss-induced effects
To study the effects of fat mass reduction on the ratio MCR1/
CD68 gene expression in adipose tissue, they were studied in
subcutaneous adipose tissue at baseline and after bariatric surgery-
induced weight loss. MCR1/CD68 ratio increased significantly
after weight loss (Figure 4) in parallel to adipogenic genes, such as
FASN, ADIPOQ, IRS1 and SLC2A4, whereas LEP (an obesity gene
marker) and IL6 (an inflammatory marker) decreased (Figure 4).
Discussion
PPARc activation is known to promote infiltration of alterna-
tively activated macrophages into mice adipose tissue, increasing
the proportion of CD206+ cells. In fact, Stienstra et al. proposed
that the rosiglitazone-induced increase in CD206+ cells is one of
the mechanisms which contribute to the beneficial effects of
rosiglitazone in parallel to adipose tissue expandability [18]. On
the other hand, it is well-known that the gene expression of
adipogenic genes (both lipogenic and insulin signaling-related
genes) is positively linked to adipose tissue expandability (lipid
storage capacity) and to protection from developing obesity-related
metabolic disturbances [19–21].
One of the main findings of the present study may suggest a
possible communication between tissues. SWAT MCR1/CD68
ratio was strongly associated with the muscle gene expression of
mitochondrial genes (PPARGC1A, TFAM and MT-CO3). As both
muscle and fat were sampled from the same abdominal territory
Figure 3. Correlation between SWAT MCR1/CD68 and ADIPOQ and muscle PPARGC1A, TFAM and MT-CO3 gene expression.
doi:10.1371/journal.pone.0070810.g003
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(fat in contact with the rectus abdominis muscle), this finding led us to
speculate a possible functional link between healthy adipose tissue
expansion and muscle mitochondrial activity, known to be
impaired in obesity-associated metabolic disturbances [22]. Both
adipose and muscle tissues secrete cytokines and other peptides,
named adipokines and myokines, which contribute to tissue
communication that is essential to maintain metabolic homeosta-
sis. For instance, adiponectin is an hormone produced specifically
by adipose tissue which increases AMPK-induced oxidative
metabolism and glucose uptake by the muscle [23,24]. The strong
association between ADIPOQ gene expression and the MRC1/
CD68 ratio led us to suggest that circulating adiponectin might
underlie in the positive connection between MRC1/CD68 and
muscle mitochondrial gene expression. Supporting this hypothesis
the positive effects of adiponectin increasing muscle fat oxidation
and mitochondrial biogenesis have been shown in an extensive
number of studies [23–28].The measurement of circulating LMW-
adiponectin concentration might be a possible limitation of this
study, since serum or plasma samples from this cohort were not
available. However, it is well-known that adiponectin biosynthesis
is exclusively produced in adipose tissue. In a recent study,
epicardial adipose tissue volume has been positively associated
with CD68 and inflammatory cytokines, and negatively with
adiponectin gene expression, being these associations strongly
linked to human coronary atherosclerosis [29]. This study supports
the possible role of adiponectin connecting adipose tissue and
muscle functionality. Otherwise, some myokines such as IL6, IL15
and irisin display beneficial effects on metabolism interacting with
the adipose tissue [30]. Exercise-induced muscle IL6 production
increases insulin-stimulated glucose metabolism in muscle and
adipose tissue, enhancing insulin-stimulated glucose disposal and
fatty acid via AMPK activation [31]. IL15 leads to reduced
adipogenesis and increased fatty acid mobilization from adipose
tissue depots [32,33]. Recently, irisin has been proposed to
mediate the beneficial effects of exercise on metabolism, inducing
browning of subcutaneous adipocytes and increasing total body
energy expenditure and resistance to obesity-associated insulin
resistance [34,35].’’
We here also describe a positive association between the
MRC1/CD68 gene expression ratio and lipogenic gene expression
in both cross-sectional and longitudinal studies. To the best of our
knowledge, this finding is novel in human adipose tissue. The
MRC1/CD68 gene expression ratio also decreased progressively
with increased fatness. The presence of CD206+ macrophages in
human adipose tissue is known to be associated with a healthy
adipose tissue expansion, i.e. an enlargement of adipose tissue
through effective recruitment of adipogenic precursor cells to the
adipogenic program in parallel to an adequate angiogenic
response and appropriate remodeling of the extracellular matrix
[36]. In this context, CD206+ macrophages are inversely
Figure 4. Effects of bariatric surgery-induced weight loss in adipose tissue MCR1/CD68, FASN, ADIPOQ, IRS1, SLC2A4, LEP and IL6 gene
expression.
doi:10.1371/journal.pone.0070810.g004
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associated with metabolic disturbances [10,37]. A small subpop-
ulation of CD206+CD11+ (less than 10% of total CD206+, which
are CD112) was also significantly associated with obesity and
insulin resistance [37].
It is extensively well shown that the number of macrophages in
adipose tissue increases with obesity-associated inflammation [1,4].
Here, we confirmed an increased CD68 gene expression in
association with obesity. In fact, the associations of CD68 gene
expression with fasting glucose, leptin and adipogenic gene
expression were closely dependent on obesity. Bariatric surgery-
induced weight loss led to increased MCR1/CD68 ratio in parallel
to the adipogenic status of SWAT, confirming a previous
immunohistochemistry study [9].
The most significant associations of both MCR1/CD68 and
CD68 levels with obesity in the cross-sectional study were mainly
found in visceral adipose tissue. Visceral adipose tissue is a well
known contributor to insulin resistance [38,39]. In fact, both
lipogenic and IRS1 gene expression are known to be significantly
decreased in visceral adipose tissue [40,41].
In conclusion, a decreased MCR1/CD68 ratio (mainly in
visceral adipose tissue) is a potential marker of obesity-associated
adipose tissue dysfunction, and linked to decreased expression of
mitochondrial genes in the muscle.
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